TNFAIP8 anticorps (N-Term)
Aperçu rapide pour TNFAIP8 anticorps (N-Term) (ABIN955272)
Antigène
Voir toutes TNFAIP8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Affinity Purified
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
-
- TNFAIP8 (Tumor Necrosis Factor, alpha-Induced Protein 8 (TNFAIP8))
-
Autre désignation
- TNFAIP8
-
Sujet
- Acts as a negative mediator of apoptosis and may play a role in tumor progression. Suppresses the TNF-mediated apoptosis by inhibiting caspase-8 activity but not the processing of procaspase-8, subsequently resulting in inhibition of BID cleavage and caspase-3 activation.Synonyms: Head and neck tumor and metastasis-related protein, MDC-3.13, NDED, NF-kappa-B-inducible DED-containing protein, SCC-S2, TNF-induced protein GG2-1, Tumor necrosis factor alpha-induced protein 8
-
ID gène
- 25816
-
NCBI Accession
- NP_001071122
Antigène
-